Reorganization of Arenavirus Genome for Development of Novel Arenavirus Live-Attenuated Vaccines (LAV)

Disclosed are compositions and methods related to recombinant arenaviruses and their use in vaccines for the treatment or prevention of an arenavirus infection.

URV Reference Number: 6-15148

Patent Information:

Title	Country	Patent No.	Issued Date
Methods and Compositions Related to Reorganization of Arenavirus Genome for Development of Novel Arenavirus Live-Attenuated Vaccines (LAV)	United States	9,943,585	4/17/2018

Category(s):

Vaccines

For Information, Contact:

Liliam Martinez Bello

Licensing Manager

University of Rochester

585-276-6600

Liliam_MartinezBello@URMC.Rochester.edu

Inventors:

Juan Carlos De La Torre

Luis Martinez-Sobrido

Masaharu Iwasaki

Beatrice Cubitt

Bookmark this page

Download as PDF